Výsledky vyhledávání - "Pemberton RJ"

Akademický článek

Variability in Test Interval Is Linked to Glycated Haemoglobin (HbA1c) Trajectory over Time.

Autor: Fryer AA; School of Medicine, Keele University, Keele, Staffordshire, UK.; Department of Clinical Biochemistry, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, Staffordshire, UK., Holland D; The Benchmarking Partnership, Alsager, Cheshire, UK., Stedman M; Res Consortium, Andover, UK., Duff CJ; School of Medicine, Keele University, Keele, Staffordshire, UK.; Department of Clinical Biochemistry, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, Staffordshire, UK., Green L; Department of Clinical Biochemistry, St. Helens & Knowsley Teaching Hospitals NHS Trust, Whiston Hospital, Prescot, UK., Scargill J; Department of Clinical Biochemistry, The Royal Oldham Hospital, The Northern Care Alliance NHS Group, Oldham, UK., Hanna FWF; Department of Diabetes and Endocrinology, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, Staffordshire, UK.; Centre for Health & Development, Staffordshire University, Staffordshire, UK., Wu P; School of Medicine, Keele University, Keele, Staffordshire, UK.; Department of Obstetrics & Gynaecology, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, Staffordshire, UK., Pemberton RJ; Diabetes UK (North Staffordshire Branch), Porthill, Stoke-on-Trent, Staffordshire, UK., Bloor C; Diabetes UK (North Staffordshire Branch), Porthill, Stoke-on-Trent, Staffordshire, UK., Heald AH; Department of Diabetes and Endocrinology, Salford Royal NHS Foundation Trust, Salford, UK.; The School of Medicine and Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, UK.

Publikováno v: Journal of diabetes research [J Diabetes Res] 2022 May 16; Vol. 2022, pp. 7093707. Date of Electronic Publication: 2022 May 16 (Print Publication: 2022).

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetes.

Autor: Harman NL; Department of Biostatistics, University of Liverpool, Liverpool, UK., Wilding JPH; Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK., Curry D; University of Liverpool, Liverpool, UK., Harris J; University of Liverpool, Liverpool, UK., Logue J; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK., Pemberton RJ; University of Liverpool, Liverpool, UK., Perreault L; Division of Endocrinology, Metabolism and Diabetes, University of Colorado, Denver, Colorado, USA.; Colorado School of Public Health, Aurora, Colorado, USA., Thompson G; University of Liverpool, Liverpool, UK., Tunis S; Center for Medical Technology Policy (CMTP), Baltimore, Maryland, USA., Williamson PR; Department of Biostatistics, University of Liverpool, Liverpool, UK.

Publikováno v: BMJ open diabetes research & care [BMJ Open Diabetes Res Care] 2019 Dec 29; Vol. 7 (1), pp. e000700. Date of Electronic Publication: 2019 Dec 29 (Print Publication: 2019).

Zobrazit plný text záznamu

Akademický článek

The frequency of testing for glycated haemoglobin, HbA1c, is linked to the probability of achieving target levels in patients with suboptimally controlled diabetes mellitus.

Autor: Duff CJ; Department of Clinical Biochemistry, University Hospitals of North Midlands, Stoke-on-Trent, Staffordshire, UK.; Institute for Applied Clinical Sciences, University of Keele, Stoke-on-Trent, Staffordshire, UK., Solis-Trapala I; Institute for Applied Clinical Sciences, University of Keele, Stoke-on-Trent, Staffordshire, UK., Driskell OJ; Department of Clinical Biochemistry, University Hospitals of North Midlands, Stoke-on-Trent, Staffordshire, UK.; Institute for Applied Clinical Sciences, University of Keele, Stoke-on-Trent, Staffordshire, UK., Holland D; The Benchmarking Partnership, Alsager, Cheshire, UK., Wright H; Department of Clinical Biochemistry, University Hospitals of North Midlands, Stoke-on-Trent, Staffordshire, UK., Waldron JL; Department of Clinical Biochemistry, Royal Wolverhampton NHS Trust, Wolverhampton, UK., Ford C; Department of Clinical Biochemistry, Royal Wolverhampton NHS Trust, Wolverhampton, UK., Scargill JJ; Department of Clinical Biochemistry, Salford Royal NHS Foundation Trust, Salford, UK., Tran M; Department of Clinical Biochemistry, University Hospitals of North Midlands, Stoke-on-Trent, Staffordshire, UK., Hanna FWF; Department of Diabetes and Endocrinology, University Hospital of North Midlands, Stoke-on-Trent, Staffordshire, UK.; Centre for Health and Development, Staffordshire University, Stoke-on-Trent, Staffordshire, UK., Pemberton RJ; Diabetes UK (North Staffordshire Branch), Porthill, Newcastle-under-Lyme, Staffordshire, UK., Heald A; The School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK., Fryer AA; Department of Clinical Biochemistry, Keele University, Institute for Applied Clinical Sciences, University Hospitals of North Midlands, Newcastle Road, Stoke-on-Trent, Staffordshire ST4 6QG, UK.

Publikováno v: Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2018 Dec 19; Vol. 57 (2), pp. 296-304.

Zobrazit plný text záznamu

Akademický článek

Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set.

Autor: Harman NL; Department of Biostatistics, Institute of Translational Medicine, University of Liverpool, Liverpool, L69 3GL, UK. n.harman@liv.ac.uk., Wilding J; Obesity and Endocrinology Clinical Research Group, Institute of Ageing and Chronic Disease, University Hospital Aintree, Longmoor Lane, Liverpool, L9 7AL, UK., Curry D; Department of Biostatistics, Institute of Translational Medicine, University of Liverpool, Liverpool, L69 3GL, UK., Harris J; Department of Biostatistics, Institute of Translational Medicine, University of Liverpool, Liverpool, L69 3GL, UK., Logue J; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK., Pemberton RJ; Department of Biostatistics, Institute of Translational Medicine, University of Liverpool, Liverpool, L69 3GL, UK., Perreault L; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.; Division of Endocrinology, Metabolism and Diabetes, Affiliate Center for Global Health, University of Colorado Anschutz Medical Campus, 13001 E. 17th Pl, Aurora, CO, 80045, USA.; Colorado School of Public Health, 13001 E. 17th Place, Mail Stop B119, Aurora, CO, 80045, USA., Thompson G; Department of Biostatistics, Institute of Translational Medicine, University of Liverpool, Liverpool, L69 3GL, UK., Tunis S; Center for Medical Technology Policy (CMTP), World Trade Center Baltimore, Baltimore, MD, USA., Williamson PR; Department of Biostatistics, Institute of Translational Medicine, University of Liverpool, Liverpool, L69 3GL, UK.

Publikováno v: Trials [Trials] 2018 Aug 07; Vol. 19 (1), pp. 427. Date of Electronic Publication: 2018 Aug 07.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Reduced testing frequency for glycated hemoglobin, HbA1c, is associated with deteriorating diabetes control.

Autor: Driskell OJ; Department of Clinical Biochemistry, University Hospital of North Staffordshire National Health Service Trust, Stoke-on-Trent, Staffordshire, U.K. Institute of Science and Technology in Medicine, University of Keele, Stoke-on-Trent, Staffordshire, U.K., Holland D; National Pathology Benchmarking Service, Department of Medicines Management, Keele University, Staffordshire, U.K., Waldron JL; Department of Clinical Biochemistry, Royal Wolverhampton National Health Service Trust, Wolverhampton, U.K., Ford C; Department of Clinical Biochemistry, Royal Wolverhampton National Health Service Trust, Wolverhampton, U.K., Scargill JJ; Department of Clinical Biochemistry, Salford Royal Hospital National Health Service Foundation Trust, U.K., Heald A; Department of Clinical Biochemistry, Salford Royal Hospital National Health Service Foundation Trust, U.K. School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, U.K., Tran M; Department of Clinical Biochemistry, University Hospital of North Staffordshire National Health Service Trust, Stoke-on-Trent, Staffordshire, U.K., Hanna FW; Department of Clinical Biochemistry, University Hospital of North Staffordshire National Health Service Trust, Stoke-on-Trent, Staffordshire, U.K. Department of Diabetes and Endocrinology, University Hospital of North Staffordshire National Health Service Trust, Stoke-on-Trent, Staffordshire, U.K., Jones PW; Institute of Science and Technology in Medicine, University of Keele, Stoke-on-Trent, Staffordshire, U.K. School of Computing and Mathematics, Keele University, Keele, Staffordshire, U.K., Pemberton RJ; Diabetes UK, North Staffordshire Branch, Newcastle-under-Lyme, Staffordshire, U.K., Fryer AA; Department of Clinical Biochemistry, University Hospital of North Staffordshire National Health Service Trust, Stoke-on-Trent, Staffordshire, U.K. Institute of Science and Technology in Medicine, University of Keele, Stoke-on-Trent, Staffordshire, U.K. anthony.fryer@uhns.nsh.uk.

Publikováno v: Diabetes care [Diabetes Care] 2014 Oct; Vol. 37 (10), pp. 2731-7.

Zobrazit plný text záznamu

Akademický článek

Inappropriate requesting of glycated hemoglobin (Hb A1c) is widespread: assessment of prevalence, impact of national guidance, and practice-to-practice variability.

Autor: Driskell OJ; Department of Clinical Biochemistry, Keele University School of Medicine, University Hospital of North Staffordshire, Stoke-on-Trent, UK., Holland D, Hanna FW, Jones PW, Pemberton RJ, Tran M, Fryer AA

Publikováno v: Clinical chemistry [Clin Chem] 2012 May; Vol. 58 (5), pp. 906-15. Date of Electronic Publication: 2012 Feb 16.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání